The Company’s provision for income tax expense for fiscal 2020 and fiscal 2019 was as follows:

	2020		2019
	(In thousands)
Current:
Federal	$	—	$	(437	)
Foreign, state and other		6		6
Deferred:
Federal		346		69
Foreign, state and other		105		10
Provision (benefit) for income tax expense	$	457	$	(352	)

The Company files a consolidated federal return and certain state and local income tax returns.

The difference between the effective rate reflected in the provision for income taxes and the amounts determined by applying the statutory federal rate of 21% to earnings before income taxes for fiscal 2020 and fiscal 2019 is analyzed below:

	2020			2019
	(In thousands)
Statutory provision	$	(805	)	$	(553	)
Foreign subsidiary		(51	)		(36	)
State taxes		(267	)		(219	)
Permanent differences		17			39
Adjustment to prior year taxes		27			(449	)
Valuation allowance		1,536			917
NOL Adjustments		—			(51	)
Provision (benefit) for income tax expense	$	457		$	(352	)

As of March 31, 2020 and March 31, 2019, the significant components of the Company’s deferred tax assets which were classified as non-current, were as follows:

	2020			2019
	(In thousands)
Deferred tax assets:
Accounts receivable reserves	$	38		$	41
Inventory reserves		164			159
Accruals		20			21
Property, plant and equipment and intangible assets		91			227
Net operating loss and credit carry forwards		2,588			1,365
Valuation allowance		(2,901	)		(1,365	)
Total deferred tax assets	$	0		$	448

The Company has $7.6 million of U.S. federal net operating loss carry forwards (“NOLs”) as of March 31, 2020.

Loss Year (Fiscal)	Included in DTA	Expiration Year (Fiscal)
2014	$2.4 million		2034
2017	$0.9 million		2036
2018	$4.0 million	2037
2019	$4.0 million	2038
2020	$4.2 million	2039

The tax benefits related to these state net operating loss carry forwards and future deductible temporary differences are recorded to the extent management believes it is more likely than not that such benefits will be realized.

The income of foreign subsidiaries before taxes was $425,000 for the fiscal year ended March 31, 2020 as compared to a loss before taxes of $419,000 for the fiscal year ended March 31, 2019, respectively.

The Company analyzed the future reasonability of recognizing its deferred tax assets at March 31, 2020. As a result, the Company concluded that a valuation allowance of approximately $2,901,000 would be recorded against the assets.

The Company is subject to examination and assessment by tax authorities in numerous jurisdictions. As of March 31, 2020, the Company’s open tax years for examination for U.S. federal tax are 2016-2019, and for U.S. states’ tax are 2011-2019. Based on the outcome of tax examinations or due to the expiration of statutes of limitations, it is reasonably possible that the unrecognized tax benefits related to uncertain tax positions taken in previously filed returns may be different from the liabilities that have been recorded for these unrecognized tax benefits. As a result, the Company may be subject to additional tax expense.

As of March 31, 2020 the Company is asserting under ASC 740-30 that all of the unremitted earnings of its foreign subsidiaries are indefinitely invested. The Company evaluates this assertion each period based on a number of factors, including the operating plans, budgets, and forecasts for both the Company and its foreign subsidiaries; the long-term and short-term financial requirements in the U.S. and in each foreign jurisdiction; and the tax consequences of any decision to repatriate earnings of foreign subsidiaries to the U.S.

The Tax Cut and Job Act (“TCJA”) establishes new tax rules designed to tax U.S. companies on global intangible low-taxed income (GILTI) earned by foreign subsidiaries. The Company has evaluated this provision of the TCJA and the application of ASC 740 and its impact is reflected in the financial statements as of March 31, 2020.